Stockscreener 앱 받기
8.30
1.78%
0.15
전일 마감가:
$8.15
열려 있는:
$7.99
하루 거래량:
221.80K
Relative Volume:
0.59
시가총액:
$510.34M
수익:
$198.53M
순이익/손실:
$-63.68M
주가수익비율:
-8.1197
EPS:
-1.0222
순현금흐름:
$-41.50M
1주 성능:
-3.32%
1개월 성능:
-7.21%
6개월 성능:
+52.20%
1년 성능:
-30.88%
1일 변동 폭
$7.85
$8.33
1주일 범위
$7.85
$8.87
52주 변동 폭
$3.92
$12.74
트리스 메디컬 컨셉트 Stock (TMCI) Company Profile
명칭
Treace Medical Concepts Inc
전화
(904) 373-5940
주소
100 PALMETTO PARK PLACE, PONTE VEDRA
TMCI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
8.30 | 510.34M | 198.53M | -63.68M | -41.50M | -1.0222 |
|
ABT
Abbott Laboratories
|
131.54 | 225.32B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
99.99 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
376.10 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.56 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.75 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
트리스 메디컬 컨셉트 Stock (TMCI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-04 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2024-12-31 | 개시 | Lake Street | Buy |
| 2024-12-17 | 재개 | JP Morgan | Neutral |
| 2024-05-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-05-08 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-05-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-05-08 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-05-08 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-05-08 | 다운그레이드 | Truist | Buy → Hold |
| 2023-09-29 | 개시 | UBS | Buy |
| 2023-05-01 | 개시 | Truist | Buy |
| 2023-04-11 | 개시 | Stephens | Equal-Weight |
| 2022-05-12 | 개시 | BTIG Research | Buy |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-18 | 개시 | JP Morgan | Overweight |
| 2021-05-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-05-18 | 개시 | SVB Leerink | Outperform |
| 2021-05-18 | 개시 | Stifel | Buy |
모두보기
트리스 메디컬 컨셉트 주식(TMCI)의 최신 뉴스
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Sees Large Decrease in Short Interest - MarketBeat
Quantbot Technologies LP Buys Shares of 9,336 Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $10.14 Consensus Target Price from Analysts - MarketBeat
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $10.14 Average PT from Analysts - Defense World
Charles Schwab Investment Management Inc. Sells 41,523 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
Treace Medical Concepts Studies of Procedures to Treat Mid-Foot Deformities Show Positive Results - Marketscreener.com
Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific Conference - The Manila Times
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Shares Sold by Charles Schwab Investment Management Inc. - Defense World
45,923 Shares in Treace Medical Concepts, Inc. (NASDAQ:TMCI) Bought by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
Bank of New York Mellon Corp Has $937,000 Stock Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace Highlights New Innovations at the 2025 ACFAS Annual Scientific Conference - TradingView
Revolutionary Bunion Treatment: Treace Launches 4 New Minimally Invasive Systems - Stock Titan
45,923 Shares in Treace Medical Concepts, Inc. (NASDAQ:TMCI) Purchased by Connor Clark & Lunn Investment Management Ltd. - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Insider Sean F. Scanlan Sells 50,000 Shares - MarketBeat
Treace Medical Concepts (NASDAQ:TMCI) Trading 4.7% HigherShould You Buy? - MarketBeat
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Sees Large Increase in Short Interest - MarketBeat
William Blair Investment Management LLC Raises Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
Treace Medical Concepts chief innovation officer sells $398k in stock - Investing.com India
Treace Medical Concepts (NASDAQ:TMCI) Price Target Lowered to $9.50 at Truist Financial - MarketBeat
Truist Financial Lowers Treace Medical Concepts (NASDAQ:TMCI) Price Target to $9.50 - Defense World
Treace Medical Concepts (NASDAQ:TMCI) Shares Gap UpStill a Buy? - MarketBeat
John Treace Spends US$524k On Treace Medical Concepts Stock - Yahoo
Rhumbline Advisers Grows Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Truist Financial Forecasts Strong Price Appreciation for Treace Medical Concepts (NASDAQ:TMCI) Stock - MarketBeat
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $10.21 Consensus PT from Analysts - Defense World
Did Treace Medical Concepts, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky InvestigateTMCI - ACCESS Newswire
Treace medical concepts CEO John Treace buys $524,064 in stock By Investing.com - Investing.com South Africa
Treace medical concepts CEO John Treace buys $524,064 in stock - Investing.com
Treace Medical Concepts (NASDAQ:TMCI) Given New $10.00 Price Target at Truist Financial - Defense World
Treace Medical Concepts (NASDAQ:TMCI) Announces Earnings Results - MarketBeat
Treace Medical’s Earnings Call Highlights Growth and Innovation - TipRanks
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2024 Earnings Call Transcript - MSN
Deep Dive Into Treace Medical Concepts Stock: Analyst Perspectives (4 Ratings) - Benzinga
UBS Adjusts Treace Medical Concepts Price Target to $10 From $7.90, Maintains Neutral Rating - Marketscreener.com
트리스 메디컬 컨셉트 (TMCI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.69%
0.15%
자본화:
|
볼륨(24시간):